Shanghai Medicilon Inc Capital Reinvestment Ratio
Shanghai Medicilon Inc capital reinvestment ratio. Shanghai Medicilon Inc (688202) has a Capital Reinvestment Ratio of 3.63x as of June 2022, meaning it reinvests 4% of its operating cash flow (CN¥9.55 Million) in capital expenditures (CN¥34.63 Million). Check Shanghai Medicilon Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Medicilon Inc (2016–2025)
Capital reinvestment ratio of Shanghai Medicilon Inc from 2016 to 2025. This chart tracks Shanghai Medicilon Inc's Capital Reinvestment Ratio across 8 annual periods. Also explore how fast is Shanghai Medicilon Inc growing its equity to track the company's year-over-year net asset growth rate.
Shanghai Medicilon Inc Capital Reinvestment Ratio by Year (2016–2025)
Shanghai Medicilon Inc capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Shanghai Medicilon Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥105.17 Million | CN¥69.03 Million | ▼ -92.7% |
| 2023 | 9.01x | CN¥33.32 Million | CN¥300.10 Million | ▲ +1293.7% |
| 2021 | 0.65x | CN¥452.94 Million | CN¥292.71 Million | ▲ +13.1% |
| 2020 | 0.57x | CN¥207.77 Million | CN¥118.72 Million | ▼ -65.8% |
| 2019 | 1.67x | CN¥58.30 Million | CN¥97.38 Million | ▲ +84.5% |
| 2018 | 0.91x | CN¥71.11 Million | CN¥64.37 Million | ▲ +14.8% |
| 2017 | 0.79x | CN¥74.70 Million | CN¥58.91 Million | ▼ -31.5% |
| 2016 | 1.15x | CN¥34.13 Million | CN¥39.31 Million | — |